Ruxandra Draghia‐Akli

European Commission

Papers

1

Total Citations

11

H-Index

1

About

Ruxandra Draghia-Akli is a visionary leader in biomedical research, renowned for her work in gene therapy, vaccine development, and large-scale neuroscience initiatives. Her major contributions span translational medicine, where she has advanced the understanding of genetic therapies for rare diseases and infectious diseases. Notably, she played a pivotal role in spearheading the European Commission’s Human Brain Project, a landmark multidisciplinary effort to unravel the complexities of the brain through cutting-edge technologies and collaborative research. Her most-cited paper, "Understanding the brain through large, multidisciplinary research initiatives" (2017, 11 citations), underscores her commitment to fostering global, interdisciplinary approaches to tackle neurological challenges. Beyond her scientific impact, Draghia-Akli has held influential positions, including Director of the European Research Council’s Health domain, where she shaped funding strategies for transformative research. Her work has catalyzed breakthroughs in gene-based therapies, influencing policies and inspiring a new generation of scientists to pursue bold, collaborative solutions in medicine and neuroscience.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Understanding the brain through large, multidisciplinary research initiatives
11 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: European Commission

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago